Abstract:By using unsymmetrical pyrazine- and pyrimidine-modulated oligo- alpha-pyridylamine ligand N-(4-methylpyrimidin-2-yl)pyrazin-2-amine (Hmpmpza) ( 1 ), 1D copper(II) coordination polymer {[Cu(mpmpza)(CH 3 COO)] (CH 3 OH)(H 2 O)} n ( 2 ) and mononuclear copper(II) complex [Cu(Hmpmpza)(NO 3 ) 2 ] ( 3 ) were first successfully synthesized and structurally characterized. In complex ( 2 ), Cu(II) is six-coordinated in an elongated octahedral geometry. The Hmpmpza molecule coordinates with the Cu(II) as a tridentate ligand, in which the pyrimidine and amine group nitrogen atoms link the coordination units to an infinite 1-D chain polymer. Extensive hydrogen bonds between amino groups, acetate anions, methanol, and water molecules are observed in 2 , resulting in a 3D network of the 2 . Complex 2 provides the first example of the complex with a modulated Hdpa ligand, in which nitrogen atoms both of the pyrazine and pyrimidine cycles participated in the coordination with the metal center. There are two crystallographically independent molecules in a mononuclear complex 3 and the Cu(II) atom is sixcoordinated in an elongated octahedral geometry. Hmpmpza in complex 3 coordinates to the Cu(II) in an antianti conformation as a bidentate ligand. The hydrogen bonds between amino groups and coordinated nitrate anions in complex 3 , link its molecules to a 1-D chain structure. However, no hydrogen bonding linkage between the 1-D chains is observed. The temperature dependence magnetic susceptibility measurement for complex 2 described by the Bonner -Fischer approximation shows a weak antiferromagnetic coupling between Cu(II) ions. The best fitting results were obtained with parameters g = 2.141, J = -0.73 cm -1 and R = 4.85 x 10 -6 . The molecular dynamics (MD) simulations of the 2- hAChE, 3-hAChE, 2-hBChE, and 3-hBChE complexes offer comprehensive insights into the stability and dynamic behavior of ligand-protein interactions. These findings contribute to a detailed understanding of the specific dynamics governing the stability of acetylcholinesterase and butyrylcholinesterase complexes.

Synthesis, Crystal Structures, Molecular Docking, in Vitro Monoamine Oxidase-B Inhibitory Activity of Transition Metal Complexes with 2-{4-[bis (4-Fluorophenyl)methyl]piperazin-1-yl} Acetic Acid

Synthesis, Crystal Structures, Molecular Docking, and in Vitro Biological Activities Evaluation of Transition Metal Complexes with 4-(3,4-dichlorophenyl) Piperazine-1-Carboxylic Acid

( S )- N -Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1 H )-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity.

Synthesis, Crystal Structures, Molecular Docking and Urease Inhibitory Activity of Nickel(ii) Complexes with 3-Pyridinyl-4-amino-5-mercapto-1,2,4-triazole

Synthesis, Crystal Structures, Molecular Docking, and in Vitro Biological Activities of Transition Metals with 4-(2,3-dichlorophenyl)piperazine-1-carboxylic Acid

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Transition Metal Complexes (m=cu, Ni and Mn) of Schiff-base Ligands: Syntheses, Crystal Structures, and Inhibitory Bioactivities Against Urease and Xanthine Oxidase

Synthesis, Crystal Structure, and Urease Inhibition Studies of Copper(Ii) and Cobalt(Iii) Complexes with Bi(2-Fluorobenzylaminoethyl)Amine

Synthesis, Inhibitory Activity and Molecular Docking Studies of Two Cu(II) Complexes Against Helicobacter Pylori Urease.

Synthesis, crystal structures and urease inhibition of nickel(II), copper(II), zinc(II) and molybdenum(VI) complexes derived from N,n'-bis(4-bromosalicylidene)-1,3-propanediamine

Synthesis, characterization, crystal structure, molecular docking, and biological studies of Cu, Ni and Co metal complexes of pyrazole

New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO.

Synthesis, Crystal Structures and Urease Inhibition of Copper(II) and Zinc(II) Complexes Derived from N,N’-Bis(4-bromosalicylidene)-1,3-propanediamine

Synthesis, properties, structure and bioactivity in vitro of mononuclear complexes of manganese and nickel with hydroxyethyltribenzimidazolylmethyl ethylene diamine

Molecular docking and biological activities of Ni(II), Cu(II) and Co(II) complexes with a new potentially hexadentate polyamine ligand; X-ray crystal structure of the Cu(II) complex

Exploring diaminomaleonitrile-derived Schiff base ligand and its complexes: Synthesis, characterization, computational insights, biological assessment, and molecular docking

Synthesis, Structure, and Urease Inhibitory Activities of Three Binuclear Copper(ii) Complexes with Protocatechuic Acid Derivative

Synthesis, characterization, crystal structures and biological activity of molybdenum complexes derived from bis(acetylacetonato)dioxomolybdenum(VI) and Schiff bases

Synthesis, Characterization and Biological Efficacies from Some New Dinuclear Metal Complexes for Base 3-(3,4-Dihydroxy-phenyl)-2-[(2-hydroxy-3-methylperoxy-benzylidene)-amino]-2-methyl Propionic Acid

Diacetyl Monoxime‐Based N∩N Donor Schiff Base and Its Zn(II) Complexes. In Vitro and In Silico Analysis

Synthesis, Characterization, Crystal Structure, Molecular Dynamics Simulations, MM-GBSA Analysis, and Bioactivity Studies of Pyrazine- and Pyrimidine-Modulated Unsymmetrical Dipyridylamide Complexes